GSK (GSK) News Today GBX 1,415.50 +19.00 (+1.36%) As of 05/20/2025 12:23 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesSustainabilityBuy This Stock Why is GSK Up Today?GSK plc (LON:GSK) shares are trading higher today, driven by a string of positive updates across analyst sentiment, regulatory approvals and pipeline progress. Analyst sentiment: Six brokerages have assigned GSK an average rating of “Moderate Buy” (five buy, one sell), according to MarketBeat and American Banking News. Regulatory approval: Japan’s Ministry of Health, Labour and Welfare approved the Blenrep combination for relapsed/refractory multiple myeloma, marking a key expansion of GSK’s oncology portfolio in Asia. Pipeline data: Nucala demonstrated consistent efficacy in COPD trials, reinforcing its potential as a growth driver in chronic respiratory disease. Safety insights: New research offers better understanding of Blenrep’s eye‐related side effects, potentially easing prescriber concerns and smoothing the therapy’s uptake. These developments strengthen GSK’s growth outlook in both oncology and respiratory sectors while underscoring continued analyst support.Posted 5h agoAI generated GSK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Japan approves GSK’s Blenrep combinations for multiple myeloma treatmentMay 19 at 7:51 AM | in.investing.comGSK plc (LON:GSK) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 19 at 2:51 AM | americanbankingnews.comJulie Brown Purchases 10 Shares of GSK plc (LON:GSK) StockMay 15, 2025 | americanbankingnews.comGSK to buy liver disease drug for up to $2 billionMay 14, 2025 | msn.comGSK plc (LON:GSK) Insider Julie Brown Acquires 10 SharesMay 14, 2025 | insidertrades.comWho’s Andrew Witty, the CEO who just stepped down at UnitedHealth?May 13, 2025 | msn.comIs GSK plc (GSK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?May 13, 2025 | msn.comGSK and Lifetime® launch original movie to raise awareness about the impact of meningitisMay 9, 2025 | finance.yahoo.comGSK Continues Share Buyback Program with Latest PurchaseMay 9, 2025 | msn.comGSK met main goal in liver disease treatment trialMay 9, 2025 | msn.comGSK plc (LON:GSK) Insider Emma Walmsley Sells 5,473 SharesMay 9, 2025 | insidertrades.comWhat’s going on with the GSK share price now?May 6, 2025 | msn.comGSK (LON:GSK) Given Buy Rating at Shore CapitalShore Capital restated a "buy" rating on shares of GSK in a research note on Wednesday.May 2, 2025 | marketbeat.comCould a new malaria jab really finish off the disease? Researchers at GSK have high hopesMay 2, 2025 | yahoo.comGSK insists it's 'well positioned' as Trump's pharma tariffs loomMay 1, 2025 | msn.comGSK’s Zejula reduces risk of progression and death in mesothelioma studyApril 30, 2025 | finance.yahoo.comGSK Sales, Profit Rise on Boost from HIV, Cancer DrugsApril 30, 2025 | msn.comFTSE 100 Live 30 April: Barclays and GSK update on tariffs, index on best run for eight yearsApril 30, 2025 | msn.comGSK Sales, Profit Rise on Boost from Cancer DrugsApril 30, 2025 | msn.comGSK Turnover, Net Profit Expected to Rise; Weaker Vaccine Performance in Focus -- Earnings PreviewApril 28, 2025 | marketwatch.comGSK plc (GSK)April 26, 2025 | finance.yahoo.comIs GSK plc (GSK) the Best Undervalued UK Stock to Buy Right Now?April 26, 2025 | msn.comGSK plc (LON:GSK) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of GSK plc (LON:GSK - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seven brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy ratApril 26, 2025 | marketbeat.comStocks Generating Improved Relative Strength: GSK ADRApril 22, 2025 | msn.comAlector concludes enrolment in Phase II trial of Alzheimer’s treatmentApril 21, 2025 | msn.comUK’s MHRA authorises GSK’s Blenrep for multiple myeloma treatmentApril 21, 2025 | msn.comPharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS?April 17, 2025 | msn.comGSK ‘s meningococcal vaccine receives positive recommendation in the U.S.April 17, 2025 | markets.businessinsider.comGSK ‘pleased’ ACIP voted in favor of using RSV vaccinesApril 17, 2025 | markets.businessinsider.comGSK's 5-In-1 Meningococcal Vaccine Gets Positive Recommendation From U.S. Advisory Committee on Immunization PracticesApril 17, 2025 | marketwatch.comPfizer, GSK to benefit as CDC panel endorses wider use of RSV shotsApril 17, 2025 | msn.comGSK Zantac appeal gets tough questions from some US judgesApril 17, 2025 | detroitnews.comGSK initiated with a Neutral at BNP Paribas ExaneApril 15, 2025 | markets.businessinsider.comGSK (LON:GSK) Reaches New 1-Year Low - Should You Sell?GSK (LON:GSK) Hits New 52-Week Low - Here's What HappenedApril 11, 2025 | marketbeat.comFTSE 100 Live 09 April: Heavy selling resumes, GSK and Astra slump on tariffs warningApril 9, 2025 | msn.comGSK slides Wednesday, underperforms marketApril 2, 2025 | marketwatch.comGSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exemptApril 2, 2025 | msn.comGSK’s share price looks a steal to me anywhere below £43.29, and here’s whyApril 2, 2025 | msn.comIs GSK plc (GSK) the Most Undervalued Healthcare Stock to Buy According to Analysts?April 1, 2025 | msn.comGSK plc (LON:GSK) Receives Average Rating of "Moderate Buy" from AnalystsShares of GSK plc (LON:GSK - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven research firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendatiMarch 30, 2025 | marketbeat.comJPMorgan Chase & Co. Reaffirms "Underweight" Rating for GSK (LON:GSK)JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of GSK in a research report on Friday.March 29, 2025 | marketbeat.comGSK Wants UK to Open Up Health Records to Boost Drug DevelopmentMarch 28, 2025 | bloomberg.comGSK accuses Pfizer of delaying Covid vaccine result until after US electionMarch 27, 2025 | yahoo.comU.S. Prosecutors Probe Tip About Timing of Pfizer VaccineMarch 26, 2025 | msn.comGSK Studying If Blockbuster Shingles Shot Reduces Dementia RiskMarch 24, 2025 | bloomberg.comIs magic suddenly happening to the dirt cheap GSK share price?March 23, 2025 | msn.comGSK plc (LON:GSK) Insider Purchases £8,120.40 in StockGSK plc (LON:GSK - Get Free Report) insider Wendy Becker acquired 536 shares of the company's stock in a transaction on Thursday, March 20th. The shares were bought at an average cost of GBX 1,515 ($19.64) per share, with a total value of £8,120.40 ($10,529.56).March 22, 2025 | marketbeat.comWendy Becker Acquires 536 Shares of GSK plc (LON:GSK) StockMarch 22, 2025 | insidertrades.comGSK (LON:GSK) Shares Cross Above 200 Day Moving Average - Here's WhyGSK (LON:GSK) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyMarch 21, 2025 | marketbeat.comGSK rallies Monday, outperforms marketMarch 17, 2025 | marketwatch.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.610.65▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼55▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZN News Today ITH News Today HCM News Today GRI News Today INDV News Today BMY News Today OGN News Today GPH News Today IGC News Today ARTL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:GSK) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GSK Stock Free GSK Stock Alerts